Alaunos Therapeutics, Inc. SEC filings TCRT
Alaunos Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 1, 2010. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 21, 2025 | — |
| DEF 14A | Proxy statement | May 21, 2025 | Jul 3, 2025 |
| PRE 14A | Preliminary proxy statement | May 9, 2025 | Jul 3, 2025 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 6, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 6, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 6, 2023 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 13, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 13, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEF 14A | Proxy statement | Apr 7, 2021 | May 19, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2021 | May 19, 2021 |
| DEFA14A | Additional proxy material | Dec 17, 2020 | — |
| DEFA14A | Additional proxy material | Dec 14, 2020 | — |
| DEFA14A | Additional proxy material | Dec 11, 2020 | — |
| DEFA14A | Additional proxy material | Dec 4, 2020 | — |
| DEFA14A | Additional proxy material | Dec 4, 2020 | — |
| DEFA14A | Additional proxy material | Nov 30, 2020 | — |
| DEFA14A | Additional proxy material | Nov 27, 2020 | — |
| DEFA14A | Additional proxy material | Nov 27, 2020 | — |
| DEFA14A | Additional proxy material | Nov 20, 2020 | — |
| DEFA14A | Additional proxy material | Nov 20, 2020 | — |
| DEFA14A | Additional proxy material | Nov 19, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DEFA14A | Additional proxy material | Nov 2, 2020 | — |
| DEFA14A | Additional proxy material | Oct 16, 2020 | — |
| DEFA14A | Additional proxy material | May 18, 2020 | — |
| DEF 14A | Proxy statement | May 18, 2020 | Jun 29, 2020 |
| PRE 14A | Preliminary proxy statement | May 8, 2020 | Jun 29, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 13, 2019 |
| DEFA14A | Additional proxy material | Sep 4, 2018 | — |
| DEFA14A | Additional proxy material | Aug 31, 2018 | — |
| DEFA14A | Additional proxy material | Aug 29, 2018 | — |
| DEFA14A | Additional proxy material | Aug 8, 2018 | — |
| DEF 14A | Proxy statement | Aug 8, 2018 | Sep 18, 2018 |
| DEFA14A | Additional proxy material | Apr 28, 2017 | — |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 14, 2017 |
| DEFA14A | Additional proxy material | Apr 28, 2016 | — |
| DEF 14A | Proxy statement | Apr 28, 2016 | Jun 15, 2016 |
| DEFA14A | Additional proxy material | May 15, 2015 | — |
| DEFA14A | Additional proxy material | Apr 30, 2015 | — |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 17, 2015 |
| DEFA14A | Additional proxy material | Apr 30, 2014 | — |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 18, 2014 |
| DEFA14A | Additional proxy material | Apr 29, 2013 | — |
| DEF 14A | Proxy statement | Apr 29, 2013 | Jun 19, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Jun 20, 2012 |
| DEF 14A | Proxy statement | May 2, 2011 | Jun 22, 2011 |
| DEF 14A | Proxy statement | May 14, 2010 | Jun 23, 2010 |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TCRT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1107421
- Former names
- ZIOPHARM ONCOLOGY INC (until Jan 4, 2022); EASYWEB INC (until Sep 19, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.